IN VITRO ANALYSIS OF ANTIBODY REGULATION IN HUMANS

人类抗体调节的体外分析

基本信息

  • 批准号:
    3172714
  • 负责人:
  • 金额:
    $ 7.11万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1979
  • 资助国家:
    美国
  • 起止时间:
    1979-05-01 至 1986-03-31
  • 项目状态:
    已结题

项目摘要

Human lymphoblastoid B cells are a subset of highly activated B cells which are induced by in vivo immunization. In vitro these B cells produce antibody without the need for T-cell help or mitogen stimulation, and the majority of the antibody production is complete by day 3 of culture. In the past year, we found that the antibody-producing capacity of these cells can be reduced in vitro by NK cells and a separate suppressor T-cell subset. In the coming year, we will determine whether all NK cells have this inhibitory capacity or, as suggested by our earlier studies, only a subset of NK cells performs this function. We will test this by selective removal and/or isolation of different subsets of NK cells using monoclonal antibodies with differing specificities. We have recently determined that the two suppressor cells recognize different target structures on the B cell, with the NK cell recognizing the transferrin receptor and the T cell recognizing a separate, as yet undefined structure. It is also clear from our studies that not all lymphoblastoid B cells are capable of being inhibited. Although the two suppressor cells recognize different target structures, they appear to recognize the same B-cell subsets. This B-cell stage appears to be a proliferating cell which has not yet developed the capacity for antibody secretion. (LB)
人淋巴母细胞样B细胞是高度活化的B细胞的一个亚群

项目成果

期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
12-O-Tetradecanoylphorbol-13-acetate (TPA) directly inhibits spontaneous immunoglobulin secretion by in vivo antigen-induced human lymphoblastoid B cells.
12-O-Tetradecanoylphorbol-13-acetate (TPA) 直接抑制体内抗原诱导的人淋巴母细胞 B 细胞的自发免疫球蛋白分泌。
  • DOI:
    10.1007/bf00915295
  • 发表时间:
    1984
  • 期刊:
  • 影响因子:
    9.1
  • 作者:
    Brieva,JA;Louie,JS;Stevens,RH
  • 通讯作者:
    Stevens,RH
Involvement of the transferrin receptor in the production and NK-induced suppression of human antibody synthesis.
转铁蛋白受体参与产生和 NK 诱导的人类抗体合成抑制。
Clonally restricted anti-IgG antibodies in rheumatoid arthritis.
类风湿性关节炎中克隆限制性抗 IgG 抗体。
  • DOI:
    10.1002/art.1780271208
  • 发表时间:
    1984
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Persselin,JE;Louie,JS;Stevens,RH
  • 通讯作者:
    Stevens,RH
Subclasses of human IgG anti-Fab antibodies: parameters for optimum detection.
人 IgG 抗 Fab 抗体的亚类:最佳检测参数。
Human in vivo antigen-induced lymphoblastoid B cells are capable of cyclical antibody production in vitro.
人体内抗原诱导的类淋巴母细胞 B 细胞能够在体外周期性产生抗体。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

RONALD H STEVENS其他文献

RONALD H STEVENS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('RONALD H STEVENS', 18)}}的其他基金

MODEL EDUCATION PROJECTS FOR HEALTH PROFESSIONS
卫生专业示范教育项目
  • 批准号:
    3016546
  • 财政年份:
    1990
  • 资助金额:
    $ 7.11万
  • 项目类别:
MODEL EDUCATION PROJECTS FOR HEALTH PROFESSIONS
卫生专业示范教育项目
  • 批准号:
    3016545
  • 财政年份:
    1990
  • 资助金额:
    $ 7.11万
  • 项目类别:
MODEL EDUCATION PROJECTS FOR HEALTH PROFESSIONS
卫生专业示范教育项目
  • 批准号:
    3016544
  • 财政年份:
    1990
  • 资助金额:
    $ 7.11万
  • 项目类别:

相似海外基金

Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
  • 批准号:
    9981001
  • 财政年份:
    2017
  • 资助金额:
    $ 7.11万
  • 项目类别:
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
  • 批准号:
    9751102
  • 财政年份:
    2017
  • 资助金额:
    $ 7.11万
  • 项目类别:
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
  • 批准号:
    9397073
  • 财政年份:
    2017
  • 资助金额:
    $ 7.11万
  • 项目类别:
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
  • 批准号:
    10223410
  • 财政年份:
    2017
  • 资助金额:
    $ 7.11万
  • 项目类别:
PREVENTING NEUTRALIZING ANTIBODY FORMATION IN MS PATIENTS WITH SC IFN-BETA (REBI
使用 SC IFN-β (REBI) 预防 MS 患者中和抗体形成
  • 批准号:
    7951676
  • 财政年份:
    2008
  • 资助金额:
    $ 7.11万
  • 项目类别:
PREVENTING NEUTRALIZING ANTIBODY FORMATION IN MS PATIENTS WITH SC IFN-β-AL
预防 SC IFN- 多发性硬化症患者中和抗体的形成
  • 批准号:
    7606036
  • 财政年份:
    2006
  • 资助金额:
    $ 7.11万
  • 项目类别:
IMMUNOLOGIC MECHANISM OF INHIBITOR ANTIBODY FORMATION IN HEMOPHILIA
血友病抑制剂抗体形成的免疫学机制
  • 批准号:
    7375053
  • 财政年份:
    2005
  • 资助金额:
    $ 7.11万
  • 项目类别:
IMMUNOLOGIC MECHANISM OF INHIBITOR ANTIBODY FORMATION IN HEMOPHILIA
血友病抑制剂抗体形成的免疫学机制
  • 批准号:
    7201220
  • 财政年份:
    2004
  • 资助金额:
    $ 7.11万
  • 项目类别:
Immunologic Mechanism of Inhibitor Antibody Formation in Hemophilia
血友病抑制剂抗体形成的免疫学机制
  • 批准号:
    6980810
  • 财政年份:
    2003
  • 资助金额:
    $ 7.11万
  • 项目类别:
INHIBITOR ANTIBODY FORMATION IN HEMOPHILIA AND VON WILLEBRAND'S DISEASE
血友病和冯·维勒布兰德病中的抑制剂抗体形成
  • 批准号:
    6419444
  • 财政年份:
    2000
  • 资助金额:
    $ 7.11万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了